Follow the 현대바이오랜드 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Chemicals sector, 현대바이오랜드 has published 28 insider filings. The latest transaction was filed on 19 February 2026 (Other). Among the most active insiders: 현대퓨처넷. The full history is accessible without an account.
28
Insider Decl.
n/a
Thresholds
n/a
14 ops.
Buy Volume
n/a
1 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.